Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nagesh K Tripathi

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|September 8, 2018
Recent Developments in Recombinant Protein-Based Dengue VaccinesNagesh K Tripathi, Ambuj Shrivastava
Frontiers in Bioengineering and Biotechnology|January 11, 2020
Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process DevelopmentNagesh K Tripathi, Ambuj Shrivastava
AIMS Microbiology|July 12, 2019
Evaluation of antibody response against recombinant domain III proteins of dengue virus type 1 and 2Nagesh K Tripathi, Ambuj Shrivastava
Bioengineered|March 19, 2014
Immunogenicity of Escherichia coli expressed envelope 2 protein of Chikungunya virusNagesh K Tripathi, Raj Priya, Ambuj Shrivastava
Applied Microbiology and Biotechnology|December 17, 2013
Production of recombinant Chikungunya virus envelope 2 protein in Escherichia coliNagesh K Tripathi, Raj Priya, Ambuj Shrivastava
Expert Opinion on Biological Therapy|July 15, 2017
Working towards dengue as a vaccine-preventable disease: challenges and opportunitiesAmbuj Shrivastava, Nagesh K Tripathi, Paban K Dash, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2010
Detection of dengue virusNagesh K Tripathi, Ambuj Shrivastava, Paban K Dash, et al.
Applied Microbiology and Biotechnology|February 24, 2010
Development of a simple fed-batch process for the high-yield production of recombinant Japanese encephalitis virus proteinNagesh K Tripathi, Jyoti Shukla, Karttik C Biswal, et al.
Applied Microbiology and Biotechnology|May 8, 2012
Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coliNagesh K Tripathi, Ambuj Shrivastava, Karttik C Biswal, et al.
New Biotechnology|May 17, 2018
Enhanced production and immunological characterization of recombinant West Nile virus envelope domain III proteinNagesh K Tripathi, Divyanshi Karothia, Ambuj Shrivastava, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|September 8, 2018
Recent Developments in Recombinant Protein-Based Dengue VaccinesNagesh K Tripathi, Ambuj Shrivastava
Frontiers in Bioengineering and Biotechnology|January 11, 2020
Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process DevelopmentNagesh K Tripathi, Ambuj Shrivastava
AIMS Microbiology|July 12, 2019
Evaluation of antibody response against recombinant domain III proteins of dengue virus type 1 and 2Nagesh K Tripathi, Ambuj Shrivastava
Bioengineered|March 19, 2014
Immunogenicity of Escherichia coli expressed envelope 2 protein of Chikungunya virusNagesh K Tripathi, Raj Priya, Ambuj Shrivastava
Applied Microbiology and Biotechnology|December 17, 2013
Production of recombinant Chikungunya virus envelope 2 protein in Escherichia coliNagesh K Tripathi, Raj Priya, Ambuj Shrivastava
Expert Opinion on Biological Therapy|July 15, 2017
Working towards dengue as a vaccine-preventable disease: challenges and opportunitiesAmbuj Shrivastava, Nagesh K Tripathi, Paban K Dash, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2010
Detection of dengue virusNagesh K Tripathi, Ambuj Shrivastava, Paban K Dash, et al.
Applied Microbiology and Biotechnology|February 24, 2010
Development of a simple fed-batch process for the high-yield production of recombinant Japanese encephalitis virus proteinNagesh K Tripathi, Jyoti Shukla, Karttik C Biswal, et al.
Applied Microbiology and Biotechnology|May 8, 2012
Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coliNagesh K Tripathi, Ambuj Shrivastava, Karttik C Biswal, et al.
New Biotechnology|May 17, 2018
Enhanced production and immunological characterization of recombinant West Nile virus envelope domain III proteinNagesh K Tripathi, Divyanshi Karothia, Ambuj Shrivastava, et al.
Pageof 2